Latest Regulatory Filings News

BlinkLab has secured North Shore Pediatric Therapy as the second US clinical site in its autism diagnostic study, enhancing recruitment and data quality with a leading Chicago-based specialist.

Gladiator Resources Limited reported a $703,000 net cash outflow for the December 2024 quarter, driven by exploration and evaluation expenses, yet maintains sufficient capital to fund operations into 2025.

Medallion Metals has secured a positive EPBC Referral decision for its Ravensthorpe Gold Project, marking a crucial milestone in its sulphide development strategy. The company aims to submit additional environmental data by March 2025, targeting final approval by Q3 2025 while progressing drilling and financing.

Carnaby Resources has completed the settlement of Tranche 2 of its recent share placement, issuing 13.5 million new shares to raise approximately $4.2 million, including participation from its board members.

Bio-Gene Technology Limited has secured A$3 million in U.S. Department of Defense grants to accelerate development of its two nature-derived insecticides, Flavocide and Qcide, targeting both military and civilian markets.

Noxopharm has successfully completed key in vitro safety tests for its SOF-SKN™ lupus drug, paving the way for the upcoming HERACLES Phase 1 clinical trial.

Aeris Environmental has updated its quarterly cash flow report, confirming ongoing operational cash outflows but expressing confidence in maintaining current cash flow levels while exploring new funding avenues.

Redivium Limited remains suspended from ASX trading following a failed entitlement offer and key director resignations, raising fresh doubts about its financial viability and governance.

Biotron Limited reported a robust net cash inflow of $1.095 million for the December 2024 quarter, driven largely by government grants, supporting its operational stability despite ongoing R&D expenses.

IODM Limited has achieved a significant milestone in its UK Education segment, raising its minimum monthly revenue threshold by 50% to GBP75k and outperforming half-year revenue forecasts.

Rewardle Holdings Limited reported a robust net cash inflow from operating activities of $3.98 million for Q4 2024, offsetting significant investing outflows and ending the quarter with $1.23 million in cash.

Savannah Goldfields Limited reported a net cash outflow in its December 2024 quarter, highlighting ongoing operational cash burn and a heavy reliance on loan facilities to sustain activities. The company’s liquidity position raises questions about its near-term funding strategy.